Please enable JavaScript to continue using this application.

Compare $CRBU vs $DWTX | Chartloom

Compare

$CRBU vs $DWTX

Caribou Biosciences Inc · Dogwood Therapeutics Inc

CRBU

Caribou Biosciences Inc

DWTX

Dogwood Therapeutics Inc

Compare $CRBU vs $DWTX

Comparing Caribou Biosciences Inc and Dogwood Therapeutics Inc

CRBUCaribou Biosciences Inc

DWTXDogwood Therapeutics Inc

CRBUCaribou Biosciences Inc

Market cap

$46M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

10.0%

YTD performance

-71.1%

52W performance

-82.8%

FCF yield

-210.7%

DWTXDogwood Therapeutics Inc

Market cap

$47M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

—

Rev growth (TTM)

—

YTD performance

-67.0%

52W performance

-78.1%

FCF yield

-32.1%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

CRBU

DWTX

Detailed metrics comparison

CRBU

Caribou Biosciences Inc

DWTX

Dogwood Therapeutics Inc

Market Cap

CRBU$46M

DWTX$47M

Enterprise Value

CRBU$19M

DWTX$37M

Price

CRBU$0.46

DWTX$1.40

P/E Ratio

CRBUN/A

DWTXN/A

P/S Ratio

CRBU4.55x

DWTX0.00x

EV/Sales

CRBU1.94x

DWTX0.00x

EV/EBITDA

CRBU0.00x

DWTX0.00x

P/B Ratio

CRBU1.33x

DWTX0.73x

P/FCF Ratio

CRBUN/A

DWTXN/A

EV/FCF

CRBU-0.20x

DWTX-2.48x

PEG Ratio

CRBUN/A

DWTXN/A

Forward P/E (NTM)

CRBUN/A

DWTXN/A

Forward P/S (NTM)

CRBUN/A

DWTXN/A

Revenue (TTM)

CRBU$10M

DWTX$0

Revenue Growth (YoY)

CRBU10.0%

DWTXN/A

Forward Rev Growth

CRBU15.8%

DWTX613.9%

Gross Margin (TTM)

CRBU0.0%

DWTX0.0%

Operating Margin (TTM)

CRBU0.0%

DWTX0.0%

EBITDA Margin (TTM)

CRBU-1065.1%

DWTX0.0%

Net Margin (TTM)

CRBU-1030.4%

DWTX0.0%

FCF Margin (TTM)

CRBU-958.5%

DWTXN/A

Net Income (TTM)

CRBU$-103M

DWTX$-25M

FCF (TTM)

CRBU$-96M

DWTX$-15M

EPS (TTM)

CRBU-$1.02

DWTX$0.00

ROE (TTM)

CRBU-8911.0%

DWTX-3591.0%

ROA (TTM)

CRBU-6247.0%

DWTX-3028.0%

ROIC (TTM)

CRBU-8911.0%

DWTX-3591.0%

Cash

CRBU$26M

DWTX$10M

Debt

CRBU$0

DWTX$0

Net Cash/Debt

CRBU$26M

DWTX$10M

Current Ratio (TTM)

CRBU6.49x

DWTX3.89x

Quick Ratio (TTM)

CRBU6.36x

DWTX3.41x

Debt/Equity (TTM)

CRBU0.00x

DWTX0.00x

Debt/Assets (TTM)

CRBU0.0%

DWTX0.0%

Interest Coverage (TTM)

CRBUN/A

DWTXN/A

Net Debt/EBITDA (TTM)

CRBU0.00x

DWTX0.00x

Beta

CRBU2.46

DWTX2.14

52W Performance

CRBU-82.8%

DWTX-78.1%

YTD Performance

CRBU-71.1%

DWTX-67.0%

% from 52W High

CRBU-87.0%

DWTX-80.1%

% from 52W Low

CRBU4.0%

DWTX9.4%

Asset Turnover (TTM)

CRBU0.06x

DWTX0.00x

FCF Yield (TTM)

CRBU-210.7%

DWTX-32.1%

Earnings Yield (TTM)

CRBU-226.5%

DWTX-52.1%

Dividend Yield (TTM)

CRBUN/A

DWTXN/A

Rule of 40

CRBU-948.5

DWTX0.0

EV/GP/RG

CRBUN/A

DWTXN/A

Ticker research

View CRBU research View DWTX research

Metric	CRBU Caribou Biosciences Inc	DWTX Dogwood Therapeutics Inc
Market & Valuation
Market Cap	$46M	$47M
Enterprise Value	$19M	$37M
Price	$0.46	$1.40
P/E Ratio	N/A	N/A
P/S Ratio	4.55x	0.00x
EV/Sales	1.94x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.33x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.20x	-2.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$10M	$0
Revenue Growth (YoY)	10.0%	N/A
Forward Rev Growth	15.8%	613.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1065.1%	0.0%
Net Margin (TTM)	-1030.4%	0.0%
FCF Margin (TTM)	-958.5%	N/A
Net Income (TTM)	$-103M	$-25M
FCF (TTM)	$-96M	$-15M
EPS (TTM)	-$1.02	$0.00
ROE (TTM)	-8911.0%	-3591.0%
ROA (TTM)	-6247.0%	-3028.0%
ROIC (TTM)	-8911.0%	-3591.0%
Financial Health
Cash	$26M	$10M
Debt	$0	$0
Net Cash/Debt	$26M	$10M
Current Ratio (TTM)	6.49x	3.89x
Quick Ratio (TTM)	6.36x	3.41x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.46	2.14
52W Performance	-82.8%	-78.1%
YTD Performance	-71.1%	-67.0%
% from 52W High	-87.0%	-80.1%
% from 52W Low	4.0%	9.4%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.00x
FCF Yield (TTM)	-210.7%	-32.1%
Earnings Yield (TTM)	-226.5%	-52.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-948.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRBU research	View DWTX research

Valuation

P/S Ratio

DWTX

0.00x

CRBU

4.55x

EV/FCF

DWTX

-2.48x

CRBU

-0.20x

Growth & revenue

Revenue Growth TTM

CRBU

10.0%

Forward Revenue Growth

DWTX

613.9%

CRBU

15.8%

Profitability & performance

Gross Margin

CRBU

0.0%

DWTX

0.0%

ROE

DWTX

-3591.0%

CRBU

-8911.0%

FCF Yield %

DWTX

-32.1%

CRBU

-210.7%

52-Week Performance

DWTX

-78.1%

CRBU

-82.8%

Detailed metrics comparison

CRBU

Caribou Biosciences Inc

DWTX

Dogwood Therapeutics Inc

Market Cap

CRBU$46M

DWTX$47M

Enterprise Value

CRBU$19M

DWTX$37M

Price

CRBU$0.46

DWTX$1.40

P/E Ratio

CRBUN/A

DWTXN/A

P/S Ratio

CRBU4.55x

DWTX0.00x

EV/Sales

CRBU1.94x

DWTX0.00x

EV/EBITDA

CRBU0.00x

DWTX0.00x

P/B Ratio

CRBU1.33x

DWTX0.73x

P/FCF Ratio

CRBUN/A

DWTXN/A

EV/FCF

CRBU-0.20x

DWTX-2.48x

PEG Ratio

CRBUN/A

DWTXN/A

Forward P/E (NTM)

CRBUN/A

DWTXN/A

Forward P/S (NTM)

CRBUN/A

DWTXN/A

Revenue (TTM)

CRBU$10M

DWTX$0

Revenue Growth (YoY)

CRBU10.0%

DWTXN/A

Forward Rev Growth

CRBU15.8%

DWTX613.9%

Gross Margin (TTM)

CRBU0.0%

DWTX0.0%

Operating Margin (TTM)

CRBU0.0%

DWTX0.0%

EBITDA Margin (TTM)

CRBU-1065.1%

DWTX0.0%

Net Margin (TTM)

CRBU-1030.4%

DWTX0.0%

FCF Margin (TTM)

CRBU-958.5%

DWTXN/A

Net Income (TTM)

CRBU$-103M

DWTX$-25M

FCF (TTM)

CRBU$-96M

DWTX$-15M

EPS (TTM)

CRBU-$1.02

DWTX$0.00

ROE (TTM)

CRBU-8911.0%

DWTX-3591.0%

ROA (TTM)

CRBU-6247.0%

DWTX-3028.0%

ROIC (TTM)

CRBU-8911.0%

DWTX-3591.0%

Cash

CRBU$26M

DWTX$10M

Debt

CRBU$0

DWTX$0

Net Cash/Debt

CRBU$26M

DWTX$10M

Current Ratio (TTM)

CRBU6.49x

DWTX3.89x

Quick Ratio (TTM)

CRBU6.36x

DWTX3.41x

Debt/Equity (TTM)

CRBU0.00x

DWTX0.00x

Debt/Assets (TTM)

CRBU0.0%

DWTX0.0%

Interest Coverage (TTM)

CRBUN/A

DWTXN/A

Net Debt/EBITDA (TTM)

CRBU0.00x

DWTX0.00x

Beta

CRBU2.46

DWTX2.14

52W Performance

CRBU-82.8%

DWTX-78.1%

YTD Performance

CRBU-71.1%

DWTX-67.0%

% from 52W High

CRBU-87.0%

DWTX-80.1%

% from 52W Low

CRBU4.0%

DWTX9.4%

Asset Turnover (TTM)

CRBU0.06x

DWTX0.00x

FCF Yield (TTM)

CRBU-210.7%

DWTX-32.1%

Earnings Yield (TTM)

CRBU-226.5%

DWTX-52.1%

Dividend Yield (TTM)

CRBUN/A

DWTXN/A

Rule of 40

CRBU-948.5

DWTX0.0

EV/GP/RG

CRBUN/A

DWTXN/A

Ticker research

View CRBU research View DWTX research

Metric	CRBU Caribou Biosciences Inc	DWTX Dogwood Therapeutics Inc
Market & Valuation
Market Cap	$46M	$47M
Enterprise Value	$19M	$37M
Price	$0.46	$1.40
P/E Ratio	N/A	N/A
P/S Ratio	4.55x	0.00x
EV/Sales	1.94x	0.00x
EV/EBITDA	0.00x	0.00x
P/B Ratio	1.33x	0.73x
P/FCF Ratio	N/A	N/A
EV/FCF	-0.20x	-2.48x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	N/A	N/A
Revenue & Growth
Revenue (TTM)	$10M	$0
Revenue Growth (YoY)	10.0%	N/A
Forward Rev Growth	15.8%	613.9%
Profitability
Gross Margin (TTM)	0.0%	0.0%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-1065.1%	0.0%
Net Margin (TTM)	-1030.4%	0.0%
FCF Margin (TTM)	-958.5%	N/A
Net Income (TTM)	$-103M	$-25M
FCF (TTM)	$-96M	$-15M
EPS (TTM)	-$1.02	$0.00
ROE (TTM)	-8911.0%	-3591.0%
ROA (TTM)	-6247.0%	-3028.0%
ROIC (TTM)	-8911.0%	-3591.0%
Financial Health
Cash	$26M	$10M
Debt	$0	$0
Net Cash/Debt	$26M	$10M
Current Ratio (TTM)	6.49x	3.89x
Quick Ratio (TTM)	6.36x	3.41x
Debt/Equity (TTM)	0.00x	0.00x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	2.46	2.14
52W Performance	-82.8%	-78.1%
YTD Performance	-71.1%	-67.0%
% from 52W High	-87.0%	-80.1%
% from 52W Low	4.0%	9.4%
Efficiency & Yields
Asset Turnover (TTM)	0.06x	0.00x
FCF Yield (TTM)	-210.7%	-32.1%
Earnings Yield (TTM)	-226.5%	-52.1%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-948.5	0.0
EV/GP/RG	N/A	N/A
Ticker research	View CRBU research	View DWTX research